Filed 1.7y ago· Sep 6, 2024
2 days to disclose
John James
RHouseMichigan-10
↓sold
AbbVie
ABBV
$1K-$15K
−5.2% vs S&P 500
Trade dateSep 4, 2024
⚑ Pharmaceutical
Recent filings
Every politician trade, as it’s filed.
Stock trades that members of the U.S. House and Senate disclose, by law, after they buy or sell. Pulled straight from the official government websites — typically posted within hours of being filed.
Showing 1–12 of 12
Filed 1.7y ago· Sep 6, 2024
2 days to discloseJohn James
RHouseMichigan-10
↓sold
Johnson & Johnson
JNJ
$1K-$15K
−5.2% vs S&P 500
Trade dateSep 4, 2024
⚑ Pharmaceutical
Filed 1.7y ago· Sep 6, 2024
2 days to discloseJohn James
RHouseMichigan-10
↓sold
Merck
MRK
$1K-$15K
−5.2% vs S&P 500
Trade dateSep 4, 2024
Stock
⚑ Pharmaceutical
Filed 1.7y ago· Sep 6, 2024
2 days to discloseJohn James
RHouseMichigan-10
↓sold
Sanofi
SNY
$1K-$15K
−5.2% vs S&P 500
Trade dateSep 4, 2024
⚑ Pharmaceutical
Filed 1.7y ago· Sep 6, 2024
2 days to discloseJohn James
RHouseMichigan-10
↓sold
Novo Nordisk
NVO
$1K-$15K
−5.2% vs S&P 500
Trade dateSep 4, 2024
⚑ Pharmaceutical
Filed 1.8y ago· Sep 2, 2024
228 days to disclose · 183 past 45-day windowJohn James
RHouseMichigan-10
↓sold
Bristol-Myers Squibb
BMY
$1K-$15K
+6.6% vs S&P 500
Trade dateJan 18, 2024
Common Stock
⚑ Pharmaceutical
Filed 1.8y ago· Sep 2, 2024
297 days to disclose · 252 past 45-day windowJohn James
RHouseMichigan-10
↑bought
AbbVie
ABBV
$1K-$15K
+40.1% vs S&P 500
Trade dateNov 10, 2023
⚑ Pharmaceutical
Filed 1.8y ago· Sep 2, 2024
297 days to disclose · 252 past 45-day windowJohn James
RHouseMichigan-10
↑bought
Johnson & Johnson
JNJ
$1K-$15K
+39.5% vs S&P 500
Trade dateNov 10, 2023
⚑ Pharmaceutical
Filed 1.8y ago· Sep 2, 2024
297 days to disclose · 252 past 45-day windowJohn James
RHouseMichigan-10
↑bought
Merck
MRK
$1K-$15K
−5.6% vs S&P 500
Trade dateNov 10, 2023
Stock
⚑ Pharmaceutical
Filed 1.8y ago· Sep 2, 2024
297 days to disclose · 252 past 45-day windowJohn James
RHouseMichigan-10
↑bought
Novo Nordisk
NVO
$1K-$15K
−72.4% vs S&P 500
Trade dateNov 10, 2023
⚑ Pharmaceutical
Filed 1.8y ago· Sep 2, 2024
297 days to disclose · 252 past 45-day windowJohn James
RHouseMichigan-10
↑bought
Sanofi
SNY
$1K-$15K
−22.3% vs S&P 500
Trade dateNov 10, 2023
⚑ Pharmaceutical
Filed 1.8y ago· Sep 2, 2024
297 days to disclose · 252 past 45-day windowJohn James
RHouseMichigan-10
↑bought
Bristol-Myers Squibb
BMY
$1K-$15K
−9.6% vs S&P 500
Trade dateNov 10, 2023
Common Stock
⚑ Pharmaceutical
| Filed | Politician | Type | Stock | Trade date | Smart move? | Size |
|---|---|---|---|---|---|---|
Sep 6, 2024 1.7y ago | John James RHouseMichigan-10 | ↓sold | AbbVie ABBV ⚑ Pharmaceutical · Energy and Commerce | Sep 4, 2024 2 days to disclose | Flat·+0.0% −5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 6, 2024 1.7y ago | John James RHouseMichigan-10 | ↓sold | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Sep 4, 2024 2 days to disclose | Flat·+0.0% −5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 6, 2024 1.7y ago | John James RHouseMichigan-10 | ↓sold | Merck MRK Stock ⚑ Pharmaceutical · Energy and Commerce | Sep 4, 2024 2 days to disclose | Flat·+0.0% −5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 6, 2024 1.7y ago | John James RHouseMichigan-10 | ↓sold | Sanofi SNY ⚑ Pharmaceutical · Energy and Commerce | Sep 4, 2024 2 days to disclose | Flat·+0.0% −5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 6, 2024 1.7y ago | John James RHouseMichigan-10 | ↓sold | Novo Nordisk NVO ⚑ Pharmaceutical · Energy and Commerce | Sep 4, 2024 2 days to disclose | Flat·+0.0% −5.2% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2024 1.8y ago | John James RHouseMichigan-10 | ↓sold | Bristol-Myers Squibb BMY Common Stock ⚑ Pharmaceutical · Energy and Commerce | Jan 18, 2024 228 days to disclose · 183 past 45-day window | Flat·+0.0% +6.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2024 1.8y ago | John James RHouseMichigan-10 | ↑bought | AbbVie ABBV ⚑ Pharmaceutical · Energy and Commerce | Nov 10, 2023 297 days to disclose · 252 past 45-day window | Good buy·+$4.6K+57.8% +40.1% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2024 1.8y ago | John James RHouseMichigan-10 | ↑bought | Johnson & Johnson JNJ ⚑ Pharmaceutical · Energy and Commerce | Nov 10, 2023 297 days to disclose · 252 past 45-day window | Good buy·+$4.6K+57.1% +39.5% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2024 1.8y ago | John James RHouseMichigan-10 | ↑bought | Merck MRK Stock ⚑ Pharmaceutical · Energy and Commerce | Nov 10, 2023 297 days to disclose · 252 past 45-day window | Good buy·+$960+12.0% −5.6% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2024 1.8y ago | John James RHouseMichigan-10 | ↑bought | Novo Nordisk NVO ⚑ Pharmaceutical · Energy and Commerce | Nov 10, 2023 297 days to disclose · 252 past 45-day window | Bad buy·−$4.4K-54.8% −72.4% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2024 1.8y ago | John James RHouseMichigan-10 | ↑bought | Sanofi SNY ⚑ Pharmaceutical · Energy and Commerce | Nov 10, 2023 297 days to disclose · 252 past 45-day window | Bad buy·−$375-4.7% −22.3% vs S&P 500 | $1K-$15K midpoint $8K |
Sep 2, 2024 1.8y ago | John James RHouseMichigan-10 | ↑bought | Bristol-Myers Squibb BMY Common Stock ⚑ Pharmaceutical · Energy and Commerce | Nov 10, 2023 297 days to disclose · 252 past 45-day window | Good buy·+$644+8.1% −9.6% vs S&P 500 | $1K-$15K midpoint $8K |